Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.

Literature DB >> 17877917

The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.

Abstract

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an enzyme that belongs to the superfamily of phospholipase A2 enzymes. Although initial studies showed that Lp-PLA2 might be protective against atherosclerosis, emerging data seem to suggest that Lp-PLA2 may be proatherogenic, which is an effect thought to be mediated by lysophosphatidylcholine and oxidized nonesterified fatty acids, two mediators generated by Lp-PLA2. This article reviews the potential mechanisms by which Lp-PLA2 may participate in the pathogenesis of atherosclerosis and its clinical manifestations, namely, coronary artery disease and stroke.

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2007 PMID： 17877917 DOI： 10.1007/s11883-007-0004-9

Source DB: PubMed Journal: Curr Atheroscler Rep ISSN： 1523-3804 Impact factor: 5.113

55 in total

1. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests.

Authors: P Greenland; S C Smith; S M Grundy
Journal: Circulation Date: 2001-10-09 Impact factor: 29.690

2. Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages.

Authors: K L Carpenter; I F Dennis; I R Challis; D P Osborn; C H Macphee; D S Leake; M J Arends; M J Mitchinson
Journal: FEBS Lett Date: 2001-09-21 Impact factor: 4.124

3. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.

Authors: G B Kudolo; P Bressler; R A DeFronzo
Journal: J Lipid Mediat Cell Signal Date: 1997-11

4. The effect of statin therapy on lipoprotein associated phospholipase A2 levels.

Authors: Michelle A Albert; Robert J Glynn; Robert L Wolfert; Paul M Ridker
Journal: Atherosclerosis Date: 2005-09 Impact factor: 5.162

5. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Authors: C J Packard; D S O'Reilly; M J Caslake; A D McMahon; I Ford; J Cooney; C H Macphee; K E Suckling; M Krishna; F E Wilkinson; A Rumley; G D Lowe
Journal: N Engl J Med Date: 2000-10-19 Impact factor: 91.245

6. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

Authors: Vasilis Tsimihodimos; Sonia-Athena P Karabina; Afroditi P Tambaki; Eleni Bairaktari; John A Goudevenos; M John Chapman; Moses Elisaf; Alexandros D Tselepis
Journal: Arterioscler Thromb Vasc Biol Date: 2002-02-01 Impact factor: 8.311

7. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial.

Authors: Steven Opal; Pierre-Francois Laterre; Edward Abraham; Bruno Francois; Xavier Wittebole; Stephen Lowry; Jean-Francois Dhainaut; Brian Warren; Thierry Dugernier; Angel Lopez; Miguel Sanchez; Ignace Demeyer; Luis Jauregui; Jose Angel Lorente; William McGee; Konrad Reinhart; Sascha Kljucar; Sonia Souza; John Pribble
Journal: Crit Care Med Date: 2004-02 Impact factor: 7.598

8. Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia.

Authors: I Leprán; A M Lefer
Journal: Basic Res Cardiol Date: 1985 Mar-Apr Impact factor: 17.165

9. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-).

Authors: H N Hodis; D M Kramsch; P Avogaro; G Bittolo-Bon; G Cazzolato; J Hwang; H Peterson; A Sevanian
Journal: J Lipid Res Date: 1994-04 Impact factor: 5.922

10. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Authors: A D Watson; M Navab; S Y Hama; A Sevanian; S M Prescott; D M Stafforini; T M McIntyre; B N Du; A M Fogelman; J A Berliner
Journal: J Clin Invest Date: 1995-02 Impact factor: 14.808

4 in total

4. Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models.

Authors: Christina Demos; Mausumi Bandyopadhyay; Bärbel Rohrer
Journal: Mol Vis Date: 2008-09-05 Impact factor: 2.367